LexDanaLexDanabeta
Inventor

Lianjun SHEN

Inventor
CN

Overview

3→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes25%
PatentTitleYear
12,570,743BCMA-targeting engineered immune cell and use thereof202612,540,191Engineered immune cells targeting BCMA and their uses thereof202611,840,575Engineered immune cells targeting BCMA and their uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD (2)· patent assignee history
2023–2026Based in CN· patent location history
2026Patents assigned to GRACELL BIOSCIENCE SHANGHAI CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD22023–2026
GRACELL BIOSCIENCE SHANGHAI CO LTD12026
Locations
LocationPatentsSpan
CN32023–2026